Clinical and Radiographic Success of Pulpotomy Using Neoputty Mineral Trioxide Aggregate Versus Pulpectomy Using Endoflas In Primary Molars With Irreversible Pulpitis: A Randomized Controlled Trial

Launched by CAIRO UNIVERSITY · Apr 3, 2025

Keywords

ClinConnect Summary

This clinical trial is studying two different dental treatments for children with a painful condition called irreversible pulpitis, which affects the inner part of their teeth. The researchers want to find out if a treatment called pulpotomy using Neoputty Mineral Trioxide Aggregate (MTA) is more effective than another treatment called pulpectomy using Endoflas. Both treatments aim to relieve pain and save the tooth.

To participate in this trial, children should be experiencing spontaneous tooth pain that lasts from a few seconds to several hours, especially when exposed to hot or cold temperatures. They should also have healthy pulp tissue that bleeds a little when the dentist checks it. However, children with teeth that cannot be fixed or who have other health issues may not be eligible. If they join the study, participants will receive one of the two treatments, and their progress will be monitored to see which method works better to relieve their pain and maintain their tooth health.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Children with spontaneous pain lasting a few seconds to several hours.
• • Pain is intensified by thermal stimulus and persists after its removal.
• • Pulp hemorrhage after performing access cavity and deroofing of pulp chamber showing reddish pink healthy pulp tissue.
• • Radicular pulp health is verified by achieving hemostasis within six minutes of compression using a cotton pellet with 2% sodium hypochlorite.
• • Absence of peri-apical or inter-radicular radiolucency, widening of periodontal ligament space, internal or external root resorption.
• Exclusion Criteria:
• • Unrestorable primary molars.
• • Primary molars with uncontrolled pulp hemorrhage or pulp necrosis.
• • Medically compromised patients who have systemic disease.
• • Uncooperative children who refuse treatment.